Navigating the Clinical Research Process for Mild Cognitive Impairment

Starting soon

Conditions studied: Mild Cognitive Impairment

In brief

Participation in medical research usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups. This trial will admit a wide range of data on the clinical trial experience of mild cognitive impairment patients to determine which factors prevail in limiting a patient's ability to join or finish a trial. It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future mild cognitive impairment patients.

Key facts

Study ID

NCT06207903

Run by

Power Life Sciences Inc.

People needed

500

Starts

2025-02-01

Expected to finish

2027-02-01

Last updated by the study team

2024-01-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Confirmed diagnosis of mild cognitive impairment
• Participant must be 18 years of age or older
• Participant must be willing and able to comply with scheduled visits, treatment schedule, laboratory tests, and other requirements of the study.

You may not qualify if…

• Pregnant or lactating woman
• Participant is actively receiving study therapy in another
• Inability to provide written informed consent

Where it is running

• Power Life Sciences — San Francisco, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.